268 related articles for article (PubMed ID: 23071666)
1. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S; Forloni M; Cifaldi L; Antonucci C; Citti A; Boldrini R; Pezzullo M; Castellano A; Russo V; van der Bruggen P; Giacomini P; Locatelli F; Fruci D
PLoS One; 2012; 7(10):e46928. PubMed ID: 23071666
[TBL] [Abstract][Full Text] [Related]
2. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.
Bao L; Dunham K; Lucas K
Cancer Immunol Immunother; 2011 Sep; 60(9):1299-307. PubMed ID: 21626030
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.
Forloni M; Albini S; Limongi MZ; Cifaldi L; Boldrini R; Nicotra MR; Giannini G; Natali PG; Giacomini P; Fruci D
Cancer Res; 2010 Feb; 70(3):916-24. PubMed ID: 20103633
[TBL] [Abstract][Full Text] [Related]
4. Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
Vertuani S; De Geer A; Levitsky V; Kogner P; Kiessling R; Levitskaya J
Cancer Res; 2003 Nov; 63(22):8006-13. PubMed ID: 14633733
[TBL] [Abstract][Full Text] [Related]
5. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
López-Albaitero A; Nayak JV; Ogino T; Machandia A; Gooding W; DeLeo AB; Ferrone S; Ferris RL
J Immunol; 2006 Mar; 176(6):3402-9. PubMed ID: 16517708
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
7. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer.
Traversari C; Meazza R; Coppolecchia M; Basso S; Verrecchia A; van der Bruggen P; Ardizzoni A; Gaggero A; Ferrini S
Gene Ther; 1997 Oct; 4(10):1029-35. PubMed ID: 9415308
[TBL] [Abstract][Full Text] [Related]
9. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
10. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocytes induce caspase-dependent and -independent cell death in neuroblastomas in a MHC-nonrestricted fashion.
De Geer A; Kiessling R; Levitsky V; Levitskaya J
J Immunol; 2006 Dec; 177(11):7540-50. PubMed ID: 17114423
[TBL] [Abstract][Full Text] [Related]
13. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes.
Spierings DC; Agsteribbe E; Wilschut J; Huckriede A
Br J Cancer; 2000 Apr; 82(8):1474-9. PubMed ID: 10780529
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.
Morandi F; Raffaghello L; Bianchi G; Meloni F; Salis A; Millo E; Ferrone S; Barnaba V; Pistoia V
Stem Cells; 2008 May; 26(5):1275-87. PubMed ID: 18292209
[TBL] [Abstract][Full Text] [Related]
16. T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.
Mimura K; Ando T; Poschke I; Mougiakakos D; Johansson CC; Ichikawa J; Okita R; Nishimura MI; Handke D; Krug N; Choudhury A; Seliger B; Kiessling R
Int J Cancer; 2011 Jan; 128(2):390-401. PubMed ID: 20715101
[TBL] [Abstract][Full Text] [Related]
17. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
19. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
20. DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.
Oda T; Nakamura R; Kasamatsu T; Gotoh N; Okuda K; Saitoh T; Handa H; Murakami H; Yamashita T
Cancer Gene Ther; 2022 Feb; 29(2):225-240. PubMed ID: 33619341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
